Marine Lipid Omega 3
Natural health product licensed in Canada
- Licence holder
- Alta Naturals Herbs & Supplements Ltd.
- NPN or DIN-HM
- 80049411
- Status
- Active licence
- Licence date
- 19 March 2014
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitis Vinifera Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 50 mg Potency : 95 % Proanthyocyanidins | 10 mg | Not calculated |
| Huile de poisson Source : Ammodytidae - en entier Potency : 90 mg Eicosapentaenoic acid | 500 mg | Not calculated |
| Huile de poisson Source : Ammodytidae - en entier Potency : 60 mg Docosahexaenoic acid | Not specified | Not calculated |
| Sélénium Source : Levure au sélénium | 25 mcg | 50 µg |
| Lécithine Source : Glycine max - Graine | 50 mg | Not calculated |
| Lécithine Source : Huile de soja | 50 mg | Not calculated |
| Vitamine E Source : Glycine max - Graine | 20.13 mg AT | Not calculated |
| Vitamine E Source : Glycine max - Graine | 30 UI | Not calculated |
| Vitamine E Source : dl-alpha-tocophérol | 20.13 mg AT | Not calculated |
| Vitamine E Source : dl-alpha-tocophérol | 30 UI | Not calculated |
| Allium sativum Source : Allium sativum - Bulbe Potency : 8 % Allicin | 10 mg | Not calculated |
Non-medicinal ingredients
Oxyde de Fer Jaune, Cire d'abeille jaune, Gélatine, Eau purifiée, Glycérine, Oxyde de fer (Fe2O3), Oxyde de fer noir
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of Ogega-3 fatty acids. Source of eicosapentaenoic acid (EPA), docosahexaenoic (DHA). A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80049411
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
- Lécithine
Read the warning, when it applies and the studies cited
- Allium sativum
Read the warning, when it applies and the studies cited
Garlic - Allium sativum
Route of administration: Oral
Cautions and warnings
Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.